Digital biology company Optic is collaborating with early-stage oncology therapeutics venture, Vindur Tx, to use Optics proprietary generative AI platform to find novel highly selective kinase inhibitors and develop more effective cancer treatments.
Vindur Tx agreed to pay Optic as much as $17.5 million for its proprietary technology to search for new ways of addressing what the company called...
French multinational pharmaceutical and healthcare company Sanofi announced a partnership with New York-based TrialSpark, which offers a technology-based model for drug development.
TrialSpark's tools aim for more efficient trial design, faster trial completion and higher quality trial data. It acquires clinical-stage drugs from pharmaceutical and biotech companies and develops them using its...
Taiwan-based digital health startup Health2Sync and French multinational pharmaceutical firm Sanofi have signed another partnership to bring digital solutions for insulin management to Japan.
WHAT IT'S ABOUT
According to a press statement, both companies will jointly develop digitised features on insulin in Japan, including connected caps for insulin and titration alerts.
Health2Sync has a mobile...
Digital chronic condition management company DarioHealth has entered into a $30 million strategic partnership with biopharma giant Sanofi to speed adoption of Dario's suite of tools in the U.S.
The agreement with the multinational pharma company's U.S. division will focus on "significantly" expanding Dario's sales to health plans and to select employers. The deal also allows the companies to...
Biopharma giant Sanofi is setting its sights on AI for drug discovery, inking a deal worth more than $100 million with tech company Exscientia.
As part of the deal, Exscientia is eligible for as much as $5.2 billion in payments for clinical development, regulatory and commercial milestones.
The deal will revolve around the development of up to 15 novel small molecule candidates in oncology and...
Health2Sync, a digital health startup based in Taiwan, and French multinational pharmaceutical firm Sanofi have extended their collaboration to soon come up with and market a new insulin management solution.
WHY IT MATTERS
The companies noted the "suboptimal" use of insulin in Taiwan and Asia. A recent study published in the Journal of Diabetes Investigation shared that approximately half of...
An initial investment of €24 million has been made by Sanofi, Capgemini, Generali and Orange to create a platform that accelerates the development of digital healthcare solutions in Europe.
The project aims to bring together scientific and technological expertise across the region and to strengthen France's position in the health technology sector, as part of the Campus PariSanté initiative.
The...
Taiwan-based digital health startup Health2Sync has entered into a partnership with pharma giant Sanofi with the aim to apply the digital solution provided by Health2Sync in 300 clinics and hospitals nationwide certified by Taiwan Diabetes Shared Care Network over the next three years.
As part of the partnership, Health2Sync will provide patient management software for healthcare professionals...
Over the last few months respiratory health has become a major area of focus within the medical community and beyond, as COVID-19 on takes its toll. However, respiratory conditions have long impacted the American public. In fact, the CDC reports that 19.2 million US adults have asthma.
As in many areas of health, today we are seeing the rise of digital for monitoring and treating respiratory...
Sanofi has announced this week that it is supporting a three-month pilot to facilitate access to an online symptom checker from British company Babylon for people concerned about digestive health issues.
The service can be accessed through the Buscopan and Dulcolax websites, Sanofi’s over the counter digestive health products.
The pharma giant is understood to have launched a similar initiative...
